What is the recommended dose of Benadryl (diphenhydramine) for an infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl (Diphenhydramine) Should NOT Be Used in Infants

Diphenhydramine is contraindicated in infants and children under 6 years of age for routine use, and the FDA explicitly states "Do not use" for children under 6 years. 1

Critical Safety Concerns

The evidence strongly advises against diphenhydramine use in this age group:

  • Between 1969 and 2006, there were 69 deaths associated with antihistamines in children under 6 years, with diphenhydramine responsible for 33 of these deaths. 2 Notably, 41 of these deaths occurred in children under 2 years of age. 2

  • The FDA and pediatric advisory committees explicitly recommend against using over-the-counter cough and cold medications, including first-generation antihistamines like diphenhydramine, in children below 6 years of age. 2

  • The American Academy of Pediatrics does not include specific dosing recommendations for diphenhydramine in neonates in their pediatric emergency medication guidelines. 3

Serious Adverse Effects in Infants

When diphenhydramine is used in neonates and infants, it can cause:

  • Significant sedation and respiratory suppression 3
  • Hypotension 3
  • Paradoxical excitement or agitation 3
  • Risk of seizures with rapid IV administration 4

Emergency Situations Only

If diphenhydramine must be used in a life-threatening emergency (such as severe anaphylaxis), the dose is 1-2 mg/kg IV/IM (maximum 50 mg), but this should only occur under direct medical supervision with close monitoring. 3, 4

However, critical caveats apply:

  • Epinephrine remains the first-line treatment for anaphylaxis, with appropriate neonatal dosing of 0.01-0.03 mg/kg of 1:10,000 solution. 3
  • Diphenhydramine should never be administered alone and is always second-line to epinephrine. 4
  • For infants and young children requiring antihistamine therapy under medical supervision, use the lower end of the dosing range (1 mg/kg). 4
  • Avoid rapid IV administration which may precipitate seizures. 3
  • Consultation with a pediatric allergist or emergency medicine specialist is strongly recommended before administering any antihistamine to a neonate. 3

Recommended Alternatives

For allergic symptoms in infants requiring treatment, second-generation antihistamines (cetirizine, loratadine, desloratadine, fexofenadine, levocetirizine) are strongly preferred due to their superior safety profile and lack of sedating effects. 2

  • Cetirizine can be dosed at 2.5 mg once or twice daily for children aged 2-5 years. 2
  • These agents have very low rates of serious adverse events in young children. 2

Clinical Approach for Infants with Allergic Symptoms

Rather than pharmacotherapy in a 2-month-old infant, focus on identifying and avoiding triggers, with immediate referral to a pediatric allergist if symptoms are severe enough to warrant treatment. 2

References

Guideline

Antihistamine Dosing for Pediatric Allergic Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of Diphenhydramine in Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diphenhydramine Syrup Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.